98%
921
2 minutes
20
Sepsis is a global health challenge, with over 49 million cases annually. Recent medical advancements have increased in-hospital survival rates to approximately 80%, but the escalating incidence of sepsis, owing to an ageing population, rise in chronic diseases, and antibiotic resistance, have also increased the number of sepsis survivors. Subsequently, there is a growing prevalence of "post-sepsis syndrome" (PSS). This syndrome includes long-term physical, medical, cognitive, and psychological issues after recovering from sepsis. PSS puts survivors at risk for hospital readmission and is associated with a reduction in health- and life span, both at short and long term, after hospital discharge. Comprehensive understanding of PSS symptoms and causative factors is vital for developing optimal care for sepsis survivors, a task of prime importance for clinicians. This review aims to elucidate our current knowledge of PSS and its relevance in enhancing post-sepsis care provided by clinicians.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546999 | PMC |
http://dx.doi.org/10.2147/IDR.S390947 | DOI Listing |
South Afr J Crit Care
May 2025
Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Background: Procalcitonin (PCT) is used in the diagnosis of sepsis. Its capability as a prognostic marker is unclear. The association between PCT and paediatric intensive care unit (PICU) outcomes has not been investigated in the South African setting.
View Article and Find Full Text PDFJ Intensive Care Med
September 2025
Medical Intensive Care Unit, 108 Military Central Hospital, Hanoi, Vietnam.
Background: Bedside ultrasound is increasingly utilized to assess muscle mass in critically ill patients, providing a noninvasive and real-time tool for early risk stratification. Muscle wasting is known to be associated with adverse outcomes in septic shock, but its prognostic value using ultrasound in this population remains underexplored. This study aimed to investigate the association between changes in rectus femoris cross-sectional area (CSA), assessed by bedside ultrasound, and 28-day mortality in patients with septic shock.
View Article and Find Full Text PDFASAIO J
September 2025
Division of Developmental Pediatrics, Department of Pediatrics, University of Alberta and Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada.
This referral center's prospective inception-cohort study from 1989 to 2000 (Era 1) and 2000 to 2022 (Era 2) included 232 consecutive children having neonatal respiratory extracorporeal membrane oxygenation (ECMO). Kindergarten-age outcomes determined in 137/139 (95.8%) survivors were Wechsler Preschool and Primary Scales of Intelligence, Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI), and sensorimotor disability, with optimal outcome defined as scores greater than or equal to 80 and without disability.
View Article and Find Full Text PDFJ Burn Care Res
September 2025
Department of Surgery, Loyola University Medical Center, Maywood, IL, US.
Shock-induced endothelial dysfunction plays a critical role in burn pathophysiology, with endothelial glycocalyx layer (EGL) degradation promoting systemic inflammation, vascular instability, and multi-organ failure. The Angiopoietin-TIE2 axis, particularly the Angiopoietin-1 (Ang-1) and Angiopoietin-2 (Ang-2) balance, regulates endothelial function; elevated Ang-2 and a high Ang-2/1 ratio are linked to worse outcomes in critical illness. While well-documented in sepsis and trauma, effects of burn-induced Angiopoietin dysregulation remains unclear.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.
Cerebral malaria (CM), a life-threatening consequence of Plasmodium falciparum infection, is associated with a high fatality rate and long-term brain impairment in survivors. Despite advances in malaria treatment, effective therapies to mitigate the severe neurological consequences of CM remain limited. Consequently, novel antimalarial drugs with different mechanisms or neuroprotective advantages are urgently required.
View Article and Find Full Text PDF